NCT05181345

Brief Summary

Many people are required to work in stressful situations combining sleep debt and hot environmental conditions. If the effect of sleep debt on cognitive performance is proven, this effect could be increased, during heat exposure, through the deleterious effects of sleep debt on thermoregulatory abilities. These alterations may favour the occurrence of accidents. The changes in cognitive performance induced by hyperthermia are also poorly characterised and often not dissociated from the effects of dehydration. Little is known about the effects of the combination of sleep debt and heat exposure on mental performance. Describing and understanding the alterations induced by this combined situation could provide a better understanding of the mechanisms explaining the deterioration of performance in hot conditions and promote the development of appropriate countermeasures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 6, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

January 14, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

April 28, 2023

Status Verified

April 1, 2023

Enrollment Period

2 years

First QC Date

December 20, 2021

Last Update Submit

April 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of errors at the Stroop test

    Written color names that differ from the color ink they are printed on will be displayed on a computer screen. In the first trial, the participant must say the written word. In the second trial, the participant must name the ink color instead. The higher the number of correct answers, the higher the score.

    Through study completion (25 months)

Study Arms (2)

Normal sleep first

The night before the first heat exposure, the participants will have a normal night at home. The night before the second heat exposure, the participants sleep will be restricted to 3 hours in bed.

Other: Sleep recording (at home)Other: Heat exposureOther: Normal sleepOther: Sleep restriction

Reduced sleep first

The night before the first heat exposure, the participants sleep will be restricted to 3 hours in bed. The night before the second heat exposure, the participants will have a normal night at home.

Other: Sleep recording (at home)Other: Heat exposureOther: Normal sleepOther: Sleep restriction

Interventions

Before both heat exposures, the sleep-wake rhythm will be measured at home for 7 days using actigraphy and a sleep diary that will have been given to him/her during the inclusion visit.

Normal sleep firstReduced sleep first

The subjects will be exposed twice (2 different visits) to heat (45°C; 60-70% humidity rate) for 3 hours in a climate chamber. The subjects will be "equipped" with various external sensors allowing the continuous recording of core temperature, mean skin temperature (9 skin measurement points), heart rate, cerebral electrical activity, cerebral oxygenation, skin vascular conductance (blood flow by laser-doppler), blood pressure and skin conductance. Neurophysiological and cognitive exploration (NPCE) includes the Stroop test, the Psychomotor Vigilance Task (PVT) and the odd-ball test.

Normal sleep firstReduced sleep first

The night before one of the two heat exposures (first visit for the "Normal sleep first" group and second visit for the "Reduced sleep first" group), the participants will have a normal night at home. The duration and quality of sleep will be measured using a connected headband (Dreem®) allowing for polysomnography.

Normal sleep firstReduced sleep first

The night before one of the two heat exposures (first visit for the "Reduced sleep first" group and second visit for the "Normal sleep first" group), the participants' sleep will be restricted. The sleep restriction will correspond to a reduced sleep period with a bedtime of 3 hours (04:00 - 07:00). This night of sleep restriction will be carried out in a sleep apartment (at the lab). The duration and quality of sleep will be measured using a connected headband (Dreem®) allowing for polysomnography.

Normal sleep firstReduced sleep first

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will be composed of healthy young male and female.

You may qualify if:

  • to 35 years old
  • Body Mass Index between 18 and 27 kg/m2
  • Body weight ≥ 54 kg

You may not qualify if:

  • Presence or history of medical pathology (cardiological, renal, hepatic, cutaneous, intestinal, neurological...)
  • Presence of a significant deviation from the normal values observed on the electrocardiogram
  • History of heat stroke
  • Known intolerance to heat (e.g. migraine sufferers)
  • Presence of a contraindication to blood sampling, notably low venous capital, belonephobia
  • Inability to ingest a capsule or refusal of the rectal probe
  • Habitual consumption of caffeine \> 500 mg per day
  • Alcohol consumption greater than the equivalent of 3 glasses of wine per week
  • Consumption of narcotics
  • Smoking \> 0.5 packet of cigarettes per day
  • Undergoing habitual medication
  • Pregnant or breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de Recherche Biomédicale des Armées

Brétigny-sur-Orge, 91223, France

RECRUITING

MeSH Terms

Conditions

Sleep Wake Disorders

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Central Study Contacts

Pierre-Emmanuel TARDO-DINO, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2021

First Posted

January 6, 2022

Study Start

January 14, 2022

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

April 28, 2023

Record last verified: 2023-04

Locations